Skip to content Skip to footer
Argatroban: Benefits, Reviews, Info, Side Effects!
Rx Details
Argatroban
Argatroban
Prescription
Anticoagulant
Drugs
Prescription Only
anticoagulant, treats heparin-induced thrombocytopenia, prevents blood clots, used during percutaneous coronary intervention
Anemia, Back Pain, Bleeding, Bradycardia, Chest Pain, Diarrhea, Dyspnea, Fever, Headache, Hematuria, Hypertension, Hypotension, Insomnia, Nausea, Pain, Rash, Sepsis, Vomiting
Argatroban is an anticoagulant medication primarily used for the treatment of heparin-induced thrombocytopenia (HIT) and as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI). The dosage of Argatroban can vary based on the specific condition being treated and the patient’s clinical status. For the treatment of HIT, the typical initial dosage is: – **2 micrograms/kg/min** administered as a continuous intravenous infusion. For patients with hepatic impairment, the dosage may need to be reduced. The infusion rate is adjusted based on the activated partial thromboplastin time (aPTT), aiming for a target aPTT of 1.5 to 3 times the baseline value, not exceeding 100 seconds. For use during PCI, the dosage may be higher, and specific protocols are followed based on the procedure and patient response. It’s important to note that dosing should be individualized and closely monitored by healthcare professionals. Always refer to specific medical guidelines or consult a healthcare provider for precise dosing information.
Heparin-induced thrombocytopenia, percutaneous coronary intervention
Argatroban has a favorable safety profile.
Warfarin, heparin, aspirin
$200 – $500
$1,200

A Synopsis of

Argatroban

Argatroban is a medication that belongs to a class of drugs known as direct thrombin inhibitors. It is commonly used in the treatment of patients who have developed blood clots, particularly in cases of heparin-induced thrombocytopenia (HIT). Argatroban works by inhibiting the activity of thrombin, a key enzyme involved in the formation of blood clots.

This medication is typically administered intravenously under the supervision of a healthcare provider in a hospital setting. The dosage and duration of treatment will vary depending on the individual patient’s condition and response to the medication. It is important to follow your healthcare provider’s instructions carefully and not to adjust the dosage on your own.

As with any medication, Argatroban may cause side effects in some patients. Common side effects may include bleeding, bruising, or injection site reactions. It is important to report any unusual or severe side effects to your healthcare provider promptly.

Before starting treatment with Argatroban, it is important to inform your healthcare provider about any other medications, supplements, or medical conditions you may have. Certain medications or medical conditions may interact with Argatroban or increase the risk of side effects.

In conclusion, Argatroban is a valuable medication used in the treatment of blood clots, particularly in cases of heparin-induced thrombocytopenia. It is important to use this medication as directed by your healthcare provider and to report any side effects promptly. If you have any questions or concerns about Argatroban, do not hesitate to discuss them with your healthcare provider.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN